Health Condition 1: J40-J47- Chronic lower respiratory diseases Health Condition 2: J459- Other and unspecified asthma Health Condition 3: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Habb-e-Hindi Zeeqi: One tablet (125mg) orally Twice Daily with Lukewarm water for four weeks
Control Intervention1: Nil: Nil
Sponsors
Central Council for Research in Unani Medicine CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: Males and females of 18-65 years 2. Objective evidence for reversible airway obstruction (>=12% and >=200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment 3. Asthma for at least 6 months before enrollment
Exclusion criteria
Exclusion criteria: The patients of Zeeq-un-Nafas (Bronchial Asthma) with following conditions will be excluded from the study: 1. FEV1/FVC ratio 2. Pregnant and lactating mother 3. Patient with other Respiratory Tract Infections, tuberculosis and malignancy. 4. Patient with co-morbidities, Diabetes Mellitus, Hepatic and Renal Insufficiency. 5. Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Zeequn Nafas(Bronchial Asthma)Timepoint: Four weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and end of treatment | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine
Outcome results
None listed